{"id":"W4408144210","doi":"10.1177/22143602241308181","title":"Long-term safety of cyclical rozanolixizumab in patients with generalized myasthenia gravis: Results from the Phase 3 MycarinG study and an open-label extension","year":2025,"lang":"en","type":"article","venue":"Journal of Neuromuscular Diseases","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network","funders":"Sanofi Genzyme; Grifols; Japan Blood Products Organization; Regeneron Pharmaceuticals; Alexion Pharmaceuticals; Biogen; Sanofi; Genentech; AstraZeneca; Amgen","keywords":"Medicine; Adverse effect; Incidence (geometry); Myasthenia gravis; Aseptic meningitis; Internal medicine; Anesthesia; Pediatrics; Meningitis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008566001,0.000550285,0.001222206,0.0003459265,0.0003145756,0.0009379136,0.0004368732,0.0006961696,0.00139271],"category_scores_gemma":[0.006150814,0.0002751634,0.002111437,0.0004742881,0.0005074508,0.0008085107,0.0005135652,0.001194574,0.0002452448],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005883292,"about_ca_system_score_gemma":0.0008769613,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003432265,"about_ca_topic_score_gemma":0.0009596847,"domain_scores_codex":[0.9967166,0.001940207,0.0003603712,0.0003563358,0.0004504636,0.0001760243],"domain_scores_gemma":[0.9933593,0.002086796,0.002850842,0.0006635141,0.0005072089,0.00053252],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.518068,0.009171262,0.1361058,0.002818742,0.01938399,0.0004026643,0.0008664285,0.002105422,0.0264509,0.0002397089,0.003477313,0.2809096],"study_design_scores_gemma":[0.2152531,0.2414028,0.5059444,0.0005000049,0.0176235,0.001708701,0.0003961721,0.002423855,0.005703764,0.0006994271,0.008183142,0.0001610426],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9888732,0.00789041,0.000482195,0.0002133391,0.00003099017,0.0004697142,0.001090108,0.00003020244,0.0009197567],"genre_scores_gemma":[0.9952906,0.001705471,0.0005848492,0.0003534053,0.00008065213,0.0003436502,0.001377263,0.00001055559,0.0002535422],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008566001,"threshold_uncertainty_score":0.04530191,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02406123906191245,"score_gpt":0.3301649406599344,"score_spread":0.306103701598022,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}